InvestorsHub Logo
icon url

dabullishbear

10/26/17 2:44 PM

#12740 RE: DayDreeming #12739

Not true. Where is your information regarding it's failure? We would've all heard about this by now.
icon url

BLight1911

10/26/17 2:52 PM

#12741 RE: DayDreeming #12739

already a failure



Based on what evidence?
icon url

Bored Lawyer

10/26/17 2:54 PM

#12742 RE: DayDreeming #12739

Oncolix has dosed 3 of the planned 18 patients in the Phase I trial.

The SEC filings clearly state that the company is finalizing contract manufacturing for additional supplies of Prolanta before proceeding to dose the remaining 15 patients. That is the reason there is no news on the trial right now.

Since you seem new to this, Phase I trials are for safety and dosing, not efficacy, and seventy-five percent (75%) of drugs that make it to Phase I move past Phase I.

Source: http://www.fdareview.org/03_drug_development.php

The Phase I trial for Prolanta is barely underway, much less a failure, and, based on past history and ODD designation, the smart money says Prolanta moves at least past Phase I.

Please back up your future assertions with facts or, at a minimum, qualify your statements with everyone's favorite, "IMO".